ArticleInternational journal of biological sciences2022

Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.

Qian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.